NewsBenzingaEdesa Biotech recibe la autorización de la FDA para su solicitud de nuevo fármaco en investigación para su ensayo clínico de fase 2 de EB06 en vitíligo Edesa Biotech recibe la autorización de la FDA para su solicitud de nuevo fármaco en investigación para su ensayo clínico de fase 2 de EB06 en vitíligo Benzinga 2026.10.15 13:16 (GMT+0) Open on Benzinga Other news US CFTC Rebuts CME's Standing to Sue, Says It Failed to Prove Harm from New Perpetual Contract Policy OpenAI reportedly seeks to accelerate ~$30 billion funding round ahead of Anthropic's IPO If You Invested $1000 In JPMorgan Chase Stock 10 Years Ago, You Would Have This Much Today Nscale and Anthropic are reportedly in talks for yet another $45 billion compute deal Here’s How Much You Would Have Made Owning eBay Stock In The Last 15 Years Comcast Stock Has an Attractive Valuation and Offers a Dividend Yield of 6.32%
US CFTC Rebuts CME's Standing to Sue, Says It Failed to Prove Harm from New Perpetual Contract Policy
